GSK‑3β mediates the effects of HNF‑1β overexpression in ovarian clear cell carcinoma

Naoki Kawahara(Nara Medical University), Hiroshi Kobayashi(Mayo Clinic in Arizona)
Experimental and Therapeutic Medicine
September 21, 2020
10.3892/etm.2020.9250
Cited by 6

Related Papers

The HNF-1β―USP28―Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma
|Oncotarget|2018|33
A novel peptide blocking cancer cell invasion by structure-based drug design
|Biomedical Reports|2017|4
Dynamic changes in the levels of maternal serum squamous cell carcinoma antigen, a potential biomarker of amniotic fluid embolism, before and after delivery in relation to the mode of delivery
|World Academy of Sciences Journal|2021|0
Inhibition of glycolysis and stimulation of mitochondrial biogenesis lead to increased ROS levels and cell death in HNF-1ß positive clear cell carcinoma
|Cell Death and Disease|2025|0